|
LV14984A
|
|
2-phenylamino-4-(pyridin-3-yl)-6-perfluoroalkylpyrimidines
|
|
LV14346A
|
|
4r,5s-enantiomer of 2-(5-methil-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
|
|
LV14345A
|
|
4-[ethyl(dimethyl)ammonio]butanoate and their use in the treatment of cardiovascular diseases
|
|
LV14274A
|
|
Combination medicinal product comprising meldonium
|
|
LV14266A
|
|
A novel therapeutically combination of nicotinic acid and meldonium
|
|
LV14268A
|
|
Medicinal products comprising meldonium succinate
|
|
LV14267A
|
|
Gamma-butyrobetaine succinate and method of preparing thereof
|
|
LV13989A
|
|
A method for obtaining 3-(2,2,2-trimethylhydrazinium)propionate ester carbonates and use thereof for meldonium preparation
|
|
LV13988A
|
|
A method for obtaining 3-(2,2,2,-trimethylhydrazinium)propionate ester sulphates and use thereof for meldonium preparation
|
|
LV13544B
|
|
Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium
|
|
LV13450B
|
|
Novel medicinal use of meldonium and pharmaceutical compositions thereof
|
